A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...
Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain. The discovery could lead to the development of new therapies for a disease triggered ...
Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.
Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, in collaboration with Osaka University and ...
Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...
Thymalin is a polypeptide complex derived from thymic preparations (often of bovine or calf origin), known to harbor among ...
New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...